Summit Financial Group, Inc. Eli Lilly & CO Transaction History

Summit Financial Group, Inc.

$279 Million
Q1 2024

A detailed history of Summit Financial Group, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Summit Financial Group, Inc. holds 10,534 shares of LLY stock, worth $9.63 Million. This represents 2.94% of its overall portfolio holdings.

Number of Shares

10,534

Previous 10,499 0.33%

Holding current value

$9.63 Million

Previous $6.12 Million 33.91%

% of portfolio

2.94%

Previous 2.36%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 05, 2024	BUY	$592.2 - $792.28 $20,727 - $27,729	35 Added 0.33%	10,534 $8.2 Million
Q4 2023 Jan 12, 2024	SELL	$525.19 - $619.13 $558,802 - $658,754	-1,064 Reduced 9.2%	10,499 $6.12 Million
Q3 2023 Oct 17, 2023	SELL	$434.7 - $599.3 $869 - $1,198	-2 Reduced 0.02%	11,563 $6.21 Million
Q2 2023 Jul 13, 2023	BUY	$350.74 - $468.98 $52,611 - $70,347	150 Added 1.31%	11,565 $5.42 Million
Q1 2023 Apr 11, 2023	SELL	$310.63 - $364.82 $776,575 - $912,050	-2,500 Reduced 17.97%	11,415 $3.92 Million

Q4 2022 Jan 09, 2023	SELL	$321.55 - $374.67 $6,431 - $7,493	-20 Reduced 0.14%	13,915 $5.09 Million
Q3 2022 Oct 12, 2022	SELL	$296.48 - $337.87 $219,395 - $250,023	-740 Reduced 5.04%	13,935 $4.51 Million
Q1 2022 Apr 08, 2022	SELL	$234.69 - $291.66 $35,203 - $43,749	-150 Reduced 1.01%	14,675 $4.2 Million
Q2 2021 Jul 06, 2021	BUY	$180.55 - $233.54 $9,930 - $12,844	55 Added 0.37%	14,825 $3.4 Million
Q1 2021 Apr 07, 2021	SELL	$164.32 - $212.72 $27,605 - $35,736	-168 Reduced 1.12%	14,770 $2.76 Million
Q4 2020 Jan 07, 2021	SELL	$130.46 - $172.63 $8,740 - $11,566	-67 Reduced 0.45%	14,938 $2.52 Million
Q2 2020 Jul 06, 2020	SELL	$136.42 - $164.18 $27,283 - $32,836	-200 Reduced 1.32%	15,005 $2.46 Million
Q3 2019 Oct 09, 2019	SELL	$106.79 - $116.16 $277,654 - $302,016	-2,600 Reduced 14.6%	15,205 $1.7 Million
Q2 2019 Jul 03, 2019	SELL	$110.79 - $129.32 $2,769 - $3,233	-25 Reduced 0.14%	17,805 $1.97 Million
Q4 2018 Jan 04, 2019	SELL	$105.9 - $118.64 $52,950 - $59,320	-500 Reduced 2.73%	17,830 $2.06 Million
Q2 2018 Jul 03, 2018	SELL	$75.7 - $86.88 $2,271 - $2,606	-30 Reduced 0.16%	18,330 $1.56 Million
Q1 2018 Apr 04, 2018	BUY	$74.21 - $87.6 $109,830 - $129,647	1,480 Added 8.77%	18,360 $1.42 Million
Q4 2017 Jan 04, 2018	SELL	$81.94 - $87.89 $9,832 - $10,546	-120 Reduced 0.71%	16,880 $1.43 Million
Q3 2017 Oct 10, 2017	BUY	$77.07 - $85.54 $1.31 Million - $1.45 Million	17,000	17,000 $1.45 Million

Others Institutions Holding LLY

# of Institutions

3,725

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $869B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Summit Financial Group, Inc. with notifications on news.

Account

Summit Financial Group, Inc. Eli Lilly & CO Transaction History